David Viveros-Carreño

81 posts

David Viveros-Carreño banner
David Viveros-Carreño

David Viveros-Carreño

@dviverosc

Gynecologic oncologist at Clínica Universitaria Colombia, @Fundacion_CTIC and @ENYGO_official Executive Group

Bogotá, D.C., Colombia Katılım Kasım 2014
329 Takip Edilen264 Takipçiler
David Viveros-Carreño retweetledi
IJGC
IJGC@IJGConline·
⚖️ De-escalation in definitive #cervical cancer surgery aims to preserve survival while reducing morbidity. ✨ Simple hysterectomy in selected tumors 🧭 Sentinel node mapping 🔬 Intra-operative tailoring 🎯 Pre-operative brachytherapy @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @RParejaGineOnco @lchiv4 @annafagottimd @HousseinELHAJJ3 @AinhoaMada @luribero26 @beatesarta @AlwynDO @PeppeParisi_ @ilkerselcukmd @VinTarantino @NSeminario27498 @dranushak88 🔗 bit.ly/4lCXs9E #IJGConline #Research #Prevention #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc
IJGC tweet media
English
2
18
37
1.8K
David Viveros-Carreño retweetledi
ESGO
ESGO@ESGO_society·
Our Congress delegates say that one of the features they most look forward to are our Tumour Board sessions, where multidisciplinary teams of experts review real-world patient cases & discuss the most effective diagnostic, treatment, & management strategies for complex cancer cases. 🙌 At ESGO 2026 in Copenhagen 🇩🇰, you’ll be able to attend 2 tumour boards, offering a valuable opportunity to observe & engage in high-level decision-making processes & explore various treatment options for difficult cases from our subspecialty. See you there! #ESGO2026 #gynonc #oncoalert
ESGO tweet media
English
0
3
6
603
AEPCC
AEPCC@aepccolposcopia·
Puedes consultar ésta y otras recomendaciones de seguimiento post tratamiento del CIN en nuestra AEPCC-guía: aepcc.org/wp-content/upl…
AEPCC tweet mediaAEPCC tweet media
Español
1
1
1
108
AEPCC
AEPCC@aepccolposcopia·
💉 Vacunación post-tratamiento Una estrategia que genera cada vez más interés. 📌 Te contamos más en el post. #AEPCC #Vacunación #VPH
AEPCC tweet mediaAEPCC tweet mediaAEPCC tweet media
Español
1
6
6
776
David Viveros-Carreño retweetledi
David Viveros-Carreño retweetledi
IJGC
IJGC@IJGConline·
📊 Impact Factor Alert! We’re proud to share that #IJGC's #ImpactFactor has increased to 4.7 in the 2024 Journal Citation Reports! 🚀 💥 We’ve also broken into the #Top10 in #Obstetrics&Gynecology, climbing from #11 to #8 📈 And we moved up 1 spot in #Oncology rankings, too! This milestone is thanks to our amazing authors, reviewers, and editorial team. Thank you for driving excellence in women’s health research! 💙 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @HelenaObermair @sofiabigardiGMD @marina_rosanu @ChakraRim @FilippoCapom @mcgouveia_ @RParejaGineOnco @lchiv4 @annafagottimd @HousseinELHAJJ3 @AinhoaMada
English
7
19
52
7.4K
David Viveros-Carreño
David Viveros-Carreño@dviverosc·
@leitaomd Actually, the SHAPE trial compared simple hysterectomy to modified radical hysterectomy (type II for the purposes of the study).
English
1
0
1
867
Mario M. Leitao, Jr
Mario M. Leitao, Jr@leitaomd·
We have SHaPE trial. Modified is unnecessary. It is either simple or true radical. That’s it
IJGC@IJGConline

Could a less-radical surgery be just as effective for early-stage cervical cancer? 🤔More on the study on modified radical hysterectomy outcomes—what’s the impact on survival? 🩺✨ @ bit.ly/4mVKR1w Take-aways: 📈 Modified radical hysterectomy use is rising for stage IB1 (≤2 cm) cervical cancer in the US (2013–2020) 🔽 Simple hysterectomy use decreased during the same period 🔬 No significant difference in LVSI or nodal metastasis between groups 💡 Simple hysterectomy group had higher use of adj RT 🩺 Survival rates for radical, modified radical, and simple hysterectomy are nearly identical (96.6%, 96.3%, 95.8%) 🧐 Less-radical surgery may be safe for early-stage patients, but more research needed @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @RParejaGineOnco @lchiv4 @annafagottimd @HousseinELHAJJ3 @AinhoaMada @HelenaObermair @sofiabigardiGMD @marina_rosanu @ChakraRim @FilippoCapom @mcgouveia_ #WeeklyPodcast #LeadArticle #IJGConline #Research #Prevention #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc

English
1
0
9
1.4K
David Viveros-Carreño retweetledi
European Network of Young Gynae Oncologists
🚨Comparing Total Mesometrial Resection (TMMR) and Radical Hysterectomy (RH) in Early Cervical Cancer: Ontogenetic vs Traditional Anatomical Approaches. Prof. David Cibula & Prof. Dr. Henrik Falconer Dr. Nicolò Bizzarri & Dr. David Viveros Link: buff.ly/loUK6PC
European Network of Young Gynae Oncologists tweet media
English
0
5
16
756
David Viveros-Carreño retweetledi
IPVS - International Papillomavirus Society
Cervical Cancer treatment studies show no survival advantage of chemoradiotherapy over radiotherapy alone. These results support a more selective approach, reducing unnecessary toxicity for patients with intermediate-risk cervical cancer @JAMAOnc 👉 bit.ly/3YC63yO
IPVS - International Papillomavirus Society tweet media
English
1
12
17
954
David Viveros-Carreño retweetledi
Núria Agustí Garcia
Núria Agustí Garcia@nagustiga·
Excited about our JAMA Oncology study! Adding CHT to RT showed no OS benefit in intermediate-risk cervical cancer, aligning with GOG 263 (#SGO2025). Hope this helps refine guidelines & improve patient care. @dviverosc @headofmelon @NiteckiRoni @RParejaGineOnco @RauhHainMD
JAMA Oncology@JAMAOnc

Adding chemotherapy to radiotherapy was not associated with improved overall survival for patients with intermediate-risk cervical cancer. ja.ma/4kATTzM @nagustiga

English
3
8
34
3.8K
David Viveros-Carreño retweetledi
Núria Agustí Garcia
Núria Agustí Garcia@nagustiga·
Our latest @JAMANetworkOpen study shows a shift toward surgical de-escalation in gynecologic oncology. Had a great chat with @pedroramirez—how can training programs adapt to keep proficiency in complex procedures? @dviverosc @headofmelon @RParejaGineOnco @RauhHainMD
IJGC@IJGConline

In this episode of the #IJGCconversations, our EIC @pedroramirezMD is joined by Dr. Núria Agustí @nagustiga to discuss: De-escalation in #GynecologicOncology Don't miss this insightful discussion! 🔗 bit.ly/4hpOYyF @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @thomasbartlMD @kfischermd @claritasantia @stephjeangill @MMontesinos_Alb @braunchristian1 @mattmarchettiMD @yates_elisemann @jhgelissen

English
0
6
22
2K
Carlos Arturo Álvarez Moreno
Carlos Arturo Álvarez Moreno@AlvarezMorenoC·
Cambio de paradigma en el manejo de la vaginosis bacteriana a partir de esta publicación en el @NEJM . Se reduce a más de la mitad la recurrencia si se trata a su pareja con antibiótico oral y 1,6 por Vs 4,2 persona-año. nejm.org/doi/full/10.10…
Español
2
27
79
4K
David Viveros-Carreño retweetledi
European Network of Young Gynae Oncologists
We had some great discussions about the exciting scientific projects ENYGO members are working on—both ongoing and upcoming. It’s inspiring to see how much amazing work is being done! If you want to hear more, make sure to join us at the ESGO Congress in Rome at ENYGO sessions.
European Network of Young Gynae Oncologists tweet media
English
0
2
5
417